Silk Road Medical Inc (SILK)
NASDAQ: SILK
· Real-Time Price · USD
27.49
-0.01 (-0.04%)
At close: Sep 16, 2024, 10:00 PM
Silk Road Medical Inc Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 51.24M | 48.48M | 47.27M | 44.44M | 45.3M | 40.13M | 40.07M | 37.37M | 33.17M | 28.02M | 28.27M | 24.7M | 26.46M | 22.05M |
Cost of Revenue | 12.74M | 11.98M | 12.47M | 12.05M | 13M | 12.53M | 10.98M | 9.31M | 9.01M | 8.58M | 7.23M | 6.08M | 6.6M | 5.54M |
Gross Profit | 38.51M | 36.5M | 34.8M | 32.38M | 32.29M | 27.61M | 29.09M | 28.07M | 24.16M | 19.44M | 21.03M | 18.63M | 19.86M | 16.52M |
Operating Income | -17.2M | -14.93M | -14.37M | -13.67M | -14.32M | -16.91M | -12.63M | -9.23M | -14.19M | -15.95M | -14.06M | -13.29M | -9.95M | -10.16M |
Interest Income | 2.32M | 2.47M | 2.62M | 2.62M | 2.43M | 2.29M | 1.78M | 617K | 122K | 12K | 15K | 42K | 47K | 95K |
Pretax Income | -16.6M | -14.14M | -13.01M | -12.79M | -13.48M | -16.46M | -12.61M | -10.32M | -15.4M | -16.68M | -14.69M | -13.88M | -10.54M | -10.69M |
Net Income | -16.6M | -14.14M | -13.01M | -12.79M | -13.48M | -16.01M | -12.6M | -10.32M | -15.4M | -16.68M | -14.69M | -13.88M | -10.54M | -10.69M |
Selling & General & Admin | 43.82M | 40.77M | 39.11M | 36.01M | 35.83M | 34.08M | 32.52M | 28.82M | 27.7M | 27.27M | 27.59M | 25.05M | 22.55M | 21.19M |
Research & Development | 11.88M | 10.66M | 10.06M | 10.05M | 10.78M | 10.43M | 9.2M | 8.47M | 10.65M | 8.12M | 7.5M | 6.87M | 7.26M | 5.48M |
Other Expenses | -4K | 48K | 477K | -2K | 110K | -144K | -28K | 4K | -50K | -116K | -12K | -3K | -6K | -3K |
Operating Expenses | 55.7M | 51.44M | 49.17M | 46.06M | 46.61M | 44.52M | 41.72M | 37.29M | 38.35M | 35.4M | 35.09M | 31.92M | 29.81M | 26.68M |
Interest Expense | 1.73M | 1.72M | 1.73M | 1.73M | 1.71M | 1.69M | 1.73M | 1.71M | 1.03M | 621K | 634K | 633K | 628K | 623K |
Selling & Marketing Expenses | n/a | n/a | 461K | n/a | n/a | n/a | 347K | n/a | n/a | n/a | 221K | n/a | n/a | n/a |
Cost & Expenses | 68.44M | 63.42M | 61.64M | 58.11M | 59.61M | 57.04M | 52.7M | 46.6M | 47.37M | 43.98M | 42.33M | 37.99M | 36.41M | 32.22M |
Income Tax Expense | n/a | n/a | 43K | n/a | n/a | -450K | -16K | n/a | n/a | -157K | 53K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 39.62M | 39.26M | 39.05M | 38.87M | 38.77M | 38.53M | 37.61M | 35.3M | 35.14M | 34.75M | 34.93M | 34.74M | 34.53M | 34.34M |
Shares Outstanding (Diluted) | 39.62M | 39.26M | 39.05M | 38.87M | 38.77M | 38.53M | 37.61M | 35.3M | 35.14M | 35.02M | 34.93M | 34.74M | 34.53M | 34.34M |
EPS (Basic) | -0.42 | -0.36 | -0.33 | -0.33 | -0.35 | -0.42 | -0.33 | -0.29 | -0.44 | -0.48 | -0.42 | -0.4 | -0.31 | -0.31 |
EPS (Diluted) | -0.42 | -0.36 | -0.33 | -0.33 | -0.35 | -0.42 | -0.33 | -0.29 | -0.44 | -0.48 | -0.42 | -0.4 | -0.31 | -0.31 |
EBITDA | -13.93M | -11.49M | -10.35M | -10.13M | -13.36M | -13.79M | -11.69M | -7.79M | -13.69M | -15.4M | -13.49M | -12.76M | -9.49M | -9.77M |
EBIT | -14.88M | -12.41M | -11.28M | -11.06M | -11.77M | -14.77M | -10.88M | -8.61M | -14.37M | -16.06M | -14.06M | -13.25M | -9.91M | -10.07M |
Depreciation & Amortization | 953K | 925K | 931K | 925K | 956K | 980K | 937K | 813K | 756K | 662K | 569K | 495K | 458K | 397K |